MBX Biosciences, Inc. Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 6.65 M | $116.41 M | 11.14% | 19.45% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 4.82 M | $84.41 M | 112.80% | 14.10% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 4.00 M | $70.05 M | 0.00% | 11.70% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2025 | 3.61 M | $63.25 M | 0.00% | 10.57% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 3.15 M | $55.13 M | 43.93% | 9.21% |
| NVP ASSOCIATES, LLC | 11/14/2025 | 2.14 M | $37.39 M | 0.00% | 6.25% |
| ECOR1 CAPITAL, LLC | 11/14/2025 | 2.12 M | $37.16 M | 84.69% | 6.21% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 2.00 M | $35.00 M | 100.00% | 5.85% |
| BLACKROCK, INC. | 11/12/2025 | 1.96 M | $34.26 M | 93.51% | 5.72% |
| VANGUARD GROUP INC | 11/07/2025 | 1.68 M | $29.35 M | 60.72% | 4.90% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.54 M | $26.94 M | -2.05% | 4.50% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 1.31 M | $22.88 M | 164.18% | 3.82% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 1.23 M | $21.44 M | 75.00% | 3.58% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.20 M | $21.02 M | 33.30% | 3.51% |
| CITADEL ADVISORS LLC | 11/14/2025 | 996.08 K | $17.43 M | 100.00% | 2.91% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 954.73 K | $16.71 M | -29.12% | 2.79% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 773.30 K | $13.53 M | -11.31% | 2.26% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 655.42 K | $11.47 M | -14.53% | 1.92% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 650.00 K | $11.38 M | 0.00% | 1.90% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 627.67 K | $10.98 M | -35.54% | 1.84% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 486.80 K | $8.52 M | 760.07% | 1.42% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 473.93 K | $8.30 M | 36.01% | 1.39% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 358.12 K | $6.27 M | 100.00% | 1.05% |
| STATE STREET CORP | 11/14/2025 | 319.27 K | $5.59 M | 20.43% | 0.93% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 283.80 K | $4.97 M | 100.00% | 0.83% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 282.68 K | $4.95 M | -55.23% | 0.83% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 282.62 K | $4.95 M | 100.00% | 0.83% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 277.78 K | $4.86 M | 100.00% | 0.81% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 275.00 K | $4.81 M | 100.00% | 0.80% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 253.00 K | $4.43 M | 5.72% | 0.74% |
| LONGAEVA PARTNERS L.P. | 11/14/2025 | 224.43 K | $3.93 M | 100.00% | 0.66% |
| PFM HEALTH SCIENCES, LP | 11/14/2025 | 221.51 K | $3.88 M | 100.00% | 0.65% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 203.20 K | $3.56 M | 799.12% | 0.59% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 200.00 K | $3.50 M | 100.00% | 0.58% |
| SECTORAL ASSET MANAGEMENT INC | 11/14/2025 | 194.90 K | $3.41 M | 1.60% | 0.57% |
| TFG ASSET MANAGEMENT GP LTD | 11/14/2025 | 177.84 K | $3.11 M | 100.00% | 0.52% |
| LMR PARTNERS LLP | 11/14/2025 | 170.10 K | $2.98 M | 100.00% | 0.50% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 170.01 K | $2.98 M | 58.17% | 0.50% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 165.00 K | $2.89 M | 100.00% | 0.48% |
| NORTHERN TRUST CORP | 11/14/2025 | 133.27 K | $2.33 M | 15.29% | 0.39% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 118.79 K | $2.08 M | -30.65% | 0.35% |
| CITADEL ADVISORS LLC | 11/14/2025 | 114.50 K | $2.00 M | 453.14% | 0.33% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/14/2025 | 100.00 K | $1.75 M | 100.00% | 0.29% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 11/14/2025 | 100.00 K | $1.75 M | 100.00% | 0.29% |
| DIADEMA PARTNERS LP | 11/14/2025 | 100.00 K | $1.75 M | 100.00% | 0.29% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 12/15/2025 | 85.00 K | $1.49 M | 100.00% | 0.25% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 85.00 K | $1.49 M | 100.00% | 0.25% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 83.77 K | $1.50 M | 100.00% | 0.24% |
| MURCHINSON LTD. | 11/14/2025 | 80.00 K | $1.40 M | 100.00% | 0.23% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 75.00 K | $1.31 M | 100.00% | 0.22% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MBX Biosciences, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 127 institutional investors and hedge funds held shares of MBX Biosciences, Inc. Common Stock. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 6.65 M
WELLINGTON MANAGEMENT GROUP LLP: 4.82 M
ORBIMED ADVISORS LLC: 4 M
NEA Management Company, LLC: 3.61 M
Deep Track Capital, LP: 3.15 M
NVP Associates, LLC: 2.14 M
139.74% of MBX Biosciences, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 47.80 M shares in the last 24 months. This purchase volume represents approximately $1.33 B in transactions.